FAQs: Treatments

How many doses of remdesivir has California received?

California has received 1,200 vials of remdesivir that has been distributed to specific counties based on their hospitals’ COVID-19 patient census.

Where did the supply of remdesivir come from? 

Gilead Sciences donated 607,000 vials for nationwide distribution

Is remdesivir an experimental drug? 

Yes. However, the FDA has allowed emergency use authorization of the drug, as explained in its fact sheet.

How will remdesivir be allocated to our hospital?

As explained in the remdisivir distribution fact sheet (link), the most recent hospital COVID-19 positive hospital census data will be used to proportionally distribute the drug. Since the minimum treatment course requires six doses of remdesivir, any county whose allocation is fewer than six will have its allocation redistributed.

How should our hospital determine how to allocate remdesivir to patients in our hospital?

CDPH has issued guidance for hospitals regarding allocation of scare medications for COVID-19. These recommendations are designed to help maximize transparent and fair allocation of remdesivir or other scare medication in a way that provides the greatest overall clinical benefits to patients with COVID-19, avoids bias, and mitigates health care disparities.